Susceptibility to cerebral infarction in the stroke-prone spontaneously hypertensive rat is inherited as a dominant trait

Stroke

Volumn 29, Issue 3, 1998, Pages 690-694

  Gratton, Julie A ^c   Sauter, Andre ^a   Rudin, Markus ^a   Lees, Kennedy R ^c   McColl, John ^c   Reid, John L ^c   Dominiczak, Anna F ^c   Macrae, I Mhairi ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NONE

Author keywords

Cerebral infarction; Genetics; Hypertension; Magnetic resonance imaging

Indexed keywords

ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; DISEASE PREDISPOSITION; HYPERTENSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

EID: 0031918642     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.3.690     Document Type: Article

References (26)

1. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:53-60.
2. Ginsberg MD, Busto R. Rodent models of cerebral ischaemia. Stroke. 1993;20:1627-1642.
3. Coyle P. Outcomes to middle cerebral artery occlusion in hypertensive and normotensive rats. Hypertension. 1984;6(suppl I):69-74.
4. Coyle P. Different susceptibilities to cerebral infarction in spontaneously hypertensive (SHR) and normotensive Sprague-Dawley rats. Stroke. 1986; 17:520-525.
5. Duverger D, Mackenzie ET. The quantitation of cerebral infarction following focal ischaemia in the rat: Influence of strain, arterial pressure, blood glucose concentration and age. J Cereb Blood Flow Metab. 1988;8:474-485.
6. Coyle P, Jokelainen PT. Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar-Kyoto (WKY) rats. Stroke. 1993;14:605-611.
7. Coyle P. Middle cerebral artery occlusion in the young rat. Stroke. 1982; 13:855-859.
8. Coyle P, Odenheimer DJ, Sing CF. Cerebral infarction after middle cerebral artery occlusion in progenies of spontaneously stroke-prone and normal rats. Stroke. 1984;15:711-716.
9. Coyle P, Heistad DD. Blood flow through cerebral collateral vessels in hypertensive and normotensive rats. Hypertension. 1986;8(suppl II):67-71.
10. Slivka A. Effect of antihypertensive therapy on focal stroke in spontaneously hypertensive rats. Stroke. 1991;22:884-888.
11. Fujii K, Weno BL, Baumbach GL, Heistad DD. Effect of antihypertensive treatment on focal cerebral infarction. Hypertension. 1992;19:713-716.
12. Jacewicz M. The hypertensive rat and predisposition to cerebral infarction. Hypertension. 1992;19:47-48.
13. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet. 1996;13:429-434.
14. Gratton J, Sauter A, Rudin M, Macrae I, Lees K, McColl J, Reid J, Dominiczak A. Susceptibility to cerebral infarction in offspring from cross-breeding stroke-prone SHR and WKY assessed with MRI. J Hypertens. 1996;13(suppl 1):S204.
15. Dominiczak AF, McLaren Y, Kusel JR, Ball DL, Goodfriend TL, Bohr DL, Reid JL. Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke prone spontaneously hypertensive rats. Am J Hypertens. 1993;6:1003-1008.
16. Davidson AO, Schork N, Jacques B, Sutcliffe RG, Reid JL, Dominiczak AF. Blood pressure in genetically hypertensive rats: influence of the Y chromosome. Hypertension. 1995;26:452-459.
17. Sauter A, Rudin M. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. Stroke. 1986;17:1228-1234.
18. Alderman DW, Grant DM. An efficient decoupler coil design which reduces heating in conductive samples in superconducting spectrometers. J Magn Res Med. 1979;36:447-450.
19. Rudin M, Sauter A. In vivo NMR in pharmaceutical research. Magn Res Imaging. 1992;10:723-731.
20. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Gaugier D. Reid JL, Macrae IM, Dominiczak AF. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet. 1997;16:364-367.
21. Nagaoka A, Iwatsuka H, Suzuoki Z, Okamoto K. Generic predisposition to stroke in the spontaneously hypertensive rats. Am J Physiol. 1976;230: 1354-1359.
22. Zhang ZG, Chopp M, Bailey F, Malinski T. Nitric oxide changes in the rat brain after transient middle cerebral artery occlusion. J Neuroi Sci. 1995; 128:22-27.
23. Cabrera CL, Bealer SL, Bohr DF. Central depressor action of nitric oxide is deficient in genetic hypertension. Am J Hypertens. 1996;9:237-241.
24. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ. Genetic hypertension and increased susceptibility to cerebral ischaemia. Neurosci Biobehav Rev. 1992;16:219-233.
25. McCulloch J. Neuroprotective drug development in stroke: blood pressure and its impact. J Hypertens Suppl. 1996;14:S131-S138.
26. Sauter A, Rudin M. Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther. 1995;274: 1008-1013.